Pub Date : 2026-02-20DOI: 10.1007/s40520-026-03337-z
Seyedeh Dalia Fazel, Lisanne Tap, Paolo Fabbietti, Andrea Corsonello, Robert Kob, Cornel C. Sieber, Regina Roller-Wirnsberger, Gerhard Wirnsberger, Ronit Ben-Romano, Itshak Melzer, Tomasz Kostka, Agnieszka Guligowska, Axel C. Carlsson, Francesc Formiga, Rafael Moreno-González, Johan Ärnlöv, Fabrizia Lattanzio, Francesco Mattace-Raso, other SCOPE investigators
Background
Statins are used for cardiovascular prevention, but their potential impact on muscle health in adults aged ≥ 75 years remains unclear.
Aims
To assess whether statin use is associated with adverse changes in muscle strength, skeletal muscle mass, and physical performance in older adults.
Methods
Data were drawn from the SCOPE study including 2,282 participants aged ≥ 75 years with complete baseline data on statin use and muscle outcomes. Muscle strength was assessed via handgrip strength, muscle mass via skeletal muscle index (SMI), and physical performance via the Short Physical Performance Battery (SPPB). Outcomes were measured at baseline and after two years. Associations with statin use were analysed cross-sectionally and longitudinally, stratified by sex, and adjusted for confounders.
Results
At baseline, 1,107 participants (48.5%) used statins (median age 79 years). Cross-sectional analyses showed no association between statin use and handgrip strength, SMI, or SPPB scores in either sex. Over two years, there were no significant between-group differences in changes over time in handgrip strength (men: − 3.1 vs. − 2.6 kg, p = 0.8; women: − 1.5 vs. − 2.5 kg, p = 0.6), SMI (men: +1.0 vs. − 0.6 kg/m², p = 0.1; women: +0.4 vs. − 0.1 kg/m², p = 0.4), or risk of SPPB decline (men: OR 1.3, 95% CI 0.9–1.8; women: OR 1.0, 95% CI 0.8–1.4).
Discussion
These findings support muscular safety of statins in well-functioning older adults, reducing concerns about potential harm.
Conclusions
In this large cohort of adults aged ≥ 75 years, statin use was not associated with adverse changes in muscle strength, muscle mass, or physical performance over two years.
他汀类药物用于心血管预防,但其对≥75岁成人肌肉健康的潜在影响尚不清楚。目的评估他汀类药物的使用是否与老年人肌肉力量、骨骼肌质量和身体表现的不良变化有关。方法数据来自SCOPE研究,包括2,282名年龄≥75岁的参与者,具有他汀类药物使用和肌肉结局的完整基线数据。通过握力评估肌肉力量,通过骨骼肌指数(SMI)评估肌肉质量,通过短体能测试(SPPB)评估体能表现。在基线和两年后测量结果。横断面和纵向分析与他汀类药物使用的关联,按性别分层,并调整混杂因素。结果基线时,1107名参与者(48.5%)使用他汀类药物(中位年龄79岁)。横断面分析显示,他汀类药物的使用与握力、SMI或SPPB评分在两性中均无关联。两年多来,在握力(男性:- 3.1 vs. - 2.6 kg, p = 0.8;女性:- 1.5 vs. - 2.5 kg, p = 0.6)、SMI(男性:+1.0 vs. - 0.6 kg/m²,p = 0.1;女性:+0.4 vs. - 0.1 kg/m²,p = 0.4)或SPPB下降风险(男性:or 1.3, 95% CI 0.9-1.8;女性:or 1.0, 95% CI 0.8 - 1.4)方面,组间无显著差异。这些发现支持他汀类药物对功能良好的老年人的肌肉安全性,减少了对潜在危害的担忧。结论:在这个年龄≥75岁的大型成人队列中,他汀类药物的使用与两年内肌肉力量、肌肉质量或身体表现的不良变化无关。
{"title":"Statin use does not impair muscle health in older adults: findings from the SCOPE study","authors":"Seyedeh Dalia Fazel, Lisanne Tap, Paolo Fabbietti, Andrea Corsonello, Robert Kob, Cornel C. Sieber, Regina Roller-Wirnsberger, Gerhard Wirnsberger, Ronit Ben-Romano, Itshak Melzer, Tomasz Kostka, Agnieszka Guligowska, Axel C. Carlsson, Francesc Formiga, Rafael Moreno-González, Johan Ärnlöv, Fabrizia Lattanzio, Francesco Mattace-Raso, other SCOPE investigators","doi":"10.1007/s40520-026-03337-z","DOIUrl":"10.1007/s40520-026-03337-z","url":null,"abstract":"<div><h3>Background</h3><p>Statins are used for cardiovascular prevention, but their potential impact on muscle health in adults aged ≥ 75 years remains unclear.</p><h3>Aims</h3><p>To assess whether statin use is associated with adverse changes in muscle strength, skeletal muscle mass, and physical performance in older adults.</p><h3>Methods</h3><p>Data were drawn from the SCOPE study including 2,282 participants aged ≥ 75 years with complete baseline data on statin use and muscle outcomes. Muscle strength was assessed via handgrip strength, muscle mass via skeletal muscle index (SMI), and physical performance via the Short Physical Performance Battery (SPPB). Outcomes were measured at baseline and after two years. Associations with statin use were analysed cross-sectionally and longitudinally, stratified by sex, and adjusted for confounders.</p><h3>Results</h3><p>At baseline, 1,107 participants (48.5%) used statins (median age 79 years). Cross-sectional analyses showed no association between statin use and handgrip strength, SMI, or SPPB scores in either sex. Over two years, there were no significant between-group differences in changes over time in handgrip strength (men: − 3.1 vs. − 2.6 kg, <i>p</i> = 0.8; women: − 1.5 vs. − 2.5 kg, <i>p</i> = 0.6), SMI (men: +1.0 vs. − 0.6 kg/m², <i>p</i> = 0.1; women: +0.4 vs. − 0.1 kg/m², <i>p</i> = 0.4), or risk of SPPB decline (men: OR 1.3, 95% CI 0.9–1.8; women: OR 1.0, 95% CI 0.8–1.4).</p><h3>Discussion</h3><p>These findings support muscular safety of statins in well-functioning older adults, reducing concerns about potential harm.</p><h3>Conclusions</h3><p>In this large cohort of adults aged ≥ 75 years, statin use was not associated with adverse changes in muscle strength, muscle mass, or physical performance over two years.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03337-z.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20DOI: 10.1007/s40520-026-03350-2
Gabriel Herrero-Beaumont, Javier Fernández-Jara, Javier Llorca, Irene Sanchez-Platero, María Garmendia, Juan Ignacio Masa, Álvaro Auñón, Patricia Rodriguez-Zamorano, Aránzazu Mediero, Felipe López-Oliva, Nasser Al-Daghri, Nicola Veronese, Jean-Yves Reginster, Raquel Largo
Background
Early knee osteoarthritis (KOA) is difficult to diagnose due to the limited sensitivity of conventional imaging and the heterogeneous presentation. This exploratory study aimed to characterize patients with early KOA symptoms by integrating arthroscopy, MRI, and synovial histopathology, and to assess the complementary value of these modalities.
Methods
We included 130 adults (> 18 years) with knee pain lasting > 3 months and inconclusive clinical and radiographic findings. Exclusion criteria included advanced radiographic OA (Kellgren–Lawrence grade > 2), previous diagnoses of musculoskeletal, rheumatic disorders or previous knee injury or surgery. MRI was performed before arthroscopy. Isolated minor findings (small focal cartilage defects or mild meniscal changes without structural disruption) were not considered exclusionary. All patients underwent diagnostic arthroscopy, and synovial biopsies were obtained from the medial patella and infrapatellar fat pad.
Results
Based on arthroscopic Outerbridge scoring, 24 patients were classified as early KOA (grades 0–2) and 55 as moderate KOA (grades 3–4). Arthroscopy detected early cartilage lesions in 60% of cases, compared with 35% by MRI. MRI WORMS scores for non-cartilaginous structures did not differ between groups. Synovial fibrosis and macrophage infiltration were higher in moderate KOA and correlated with WOMAC pain.
Conclusion
Arthroscopy was more sensitive than MRI for early cartilage damage, while MRI provided complementary information on non-cartilaginous structures. Synovial inflammation and fibrosis were already present at early stages. An integrated approach combining arthroscopy, MRI, and synovial histopathology enables refined structural and biological characterization of early KOA and may support patient stratification in disease-modifying trials.
{"title":"Integration of gold standard arthroscopy, MRI and synovial histopathology outcomes for enhancing early knee osteoarthritis diagnosis","authors":"Gabriel Herrero-Beaumont, Javier Fernández-Jara, Javier Llorca, Irene Sanchez-Platero, María Garmendia, Juan Ignacio Masa, Álvaro Auñón, Patricia Rodriguez-Zamorano, Aránzazu Mediero, Felipe López-Oliva, Nasser Al-Daghri, Nicola Veronese, Jean-Yves Reginster, Raquel Largo","doi":"10.1007/s40520-026-03350-2","DOIUrl":"10.1007/s40520-026-03350-2","url":null,"abstract":"<div><h3>Background</h3><p>Early knee osteoarthritis (KOA) is difficult to diagnose due to the limited sensitivity of conventional imaging and the heterogeneous presentation. This exploratory study aimed to characterize patients with early KOA symptoms by integrating arthroscopy, MRI, and synovial histopathology, and to assess the complementary value of these modalities.</p><h3>Methods</h3><p>We included 130 adults (> 18 years) with knee pain lasting > 3 months and inconclusive clinical and radiographic findings. Exclusion criteria included advanced radiographic OA (Kellgren–Lawrence grade > 2), previous diagnoses of musculoskeletal, rheumatic disorders or previous knee injury or surgery. MRI was performed before arthroscopy. Isolated minor findings (small focal cartilage defects or mild meniscal changes without structural disruption) were not considered exclusionary. All patients underwent diagnostic arthroscopy, and synovial biopsies were obtained from the medial patella and infrapatellar fat pad.</p><h3>Results</h3><p>Based on arthroscopic Outerbridge scoring, 24 patients were classified as early KOA (grades 0–2) and 55 as moderate KOA (grades 3–4). Arthroscopy detected early cartilage lesions in 60% of cases, compared with 35% by MRI. MRI WORMS scores for non-cartilaginous structures did not differ between groups. Synovial fibrosis and macrophage infiltration were higher in moderate KOA and correlated with WOMAC pain.</p><h3>Conclusion</h3><p>Arthroscopy was more sensitive than MRI for early cartilage damage, while MRI provided complementary information on non-cartilaginous structures. Synovial inflammation and fibrosis were already present at early stages. An integrated approach combining arthroscopy, MRI, and synovial histopathology enables refined structural and biological characterization of early KOA and may support patient stratification in disease-modifying trials.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03350-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20DOI: 10.1007/s40520-026-03344-0
Zahra Bahadoran, Zahra Nozari, Fereidoun Azizi
Aim
This study aimed to examine the trends and determinants of dietary supplement use and to assess the prevalence and predictors of potential drug-supplement interactions among older adults over a 16-year follow-up.
Methods
This repeated cross-sectional study included adults aged ≥ 50 years who participated in the third (2006–2008; n = 3,484), fourth (2009–2011; n = 4,020), fifth (2012–2014; n = 4,342), sixth (2015–2017; n = 4,598), and seventh (2018–2022; n = 4,750) examinations of the Tehran Lipid and Glucose Study (TLGS). Information on dietary supplement use, including individual vitamin supplements and prescription medication use was collected using standardized questionnaires. Trends in supplement use and participant characteristics were evaluated across study phases. Clinically relevant mild-to-moderate potential drug-supplement interactions were defined as the concurrent use of specific dietary supplements and commonly prescribed medications and were classified according to Stockley’s framework. Multivariable logistic regression models were used to identify factors associated with dietary supplement use and potential drug-supplement interactions in the 2018–2022 examination.
Results
Over 16 years, dietary supplement use increased more than 2-fold from 10.4% to 21.1%, mainly from increases in thiamin (2.2% to 13.4%), cobalamin (1.8% to 9.8%), vitamin C (1.3% to 7.9%), vitamin E (1.8% to 8.7%), and zinc (0.2% to 3.3%). Female sex, higher education, and diabetes were associated with higher likelihood of supplement use. In 2018–2022, 4.8% of participants had potential drug-supplement interactions, most commonly vitamin E with aspirin (2.3%) and magnesium or potassium with antihypertensive medications. The likelihood of potential drug-supplement interactions was higher in women (OR = 2.03, 95%CI = 1.61–2.56), participants with primary education (OR = 1.45, 95% CI = 1.09–1.96), smokers (OR = 1.50, 95%CI = 1.07–2.12), and individuals with diabetes (OR = 2.80, 95%CI = 2.13–3.68), hypertension (OR = 2.20, 95%CI = 1.78–2.73), chronic kidney disease (OR = 2.35, 95%CI = 1.88–2.94), or multimorbidity (OR = 2.46, 95%CI = 1.85–3.26).
Conclusion
Over 16 years, supplement use increased among older adults, especially B-complex vitamins, vitamin C, vitamin E, and zinc, with a low but clinically relevant prevalence of drug-supplement interactions.
{"title":"Trends and determinants of dietary supplement use and potential drug- supplement interactions in older adults: a 16-years follow-up in the Tehran lipid and glucose study","authors":"Zahra Bahadoran, Zahra Nozari, Fereidoun Azizi","doi":"10.1007/s40520-026-03344-0","DOIUrl":"10.1007/s40520-026-03344-0","url":null,"abstract":"<div><h3>Aim</h3><p>This study aimed to examine the trends and determinants of dietary supplement use and to assess the prevalence and predictors of potential drug-supplement interactions among older adults over a 16-year follow-up.</p><h3>Methods</h3><p>This repeated cross-sectional study included adults aged ≥ 50 years who participated in the third (2006–2008; <i>n</i> = 3,484), fourth (2009–2011; <i>n</i> = 4,020), fifth (2012–2014; <i>n</i> = 4,342), sixth (2015–2017; <i>n</i> = 4,598), and seventh (2018–2022; <i>n</i> = 4,750) examinations of the Tehran Lipid and Glucose Study (TLGS). Information on dietary supplement use, including individual vitamin supplements and prescription medication use was collected using standardized questionnaires. Trends in supplement use and participant characteristics were evaluated across study phases. Clinically relevant mild-to-moderate potential drug-supplement interactions were defined as the concurrent use of specific dietary supplements and commonly prescribed medications and were classified according to Stockley’s framework. Multivariable logistic regression models were used to identify factors associated with dietary supplement use and potential drug-supplement interactions in the 2018–2022 examination.</p><h3>Results</h3><p>Over 16 years, dietary supplement use increased more than 2-fold from 10.4% to 21.1%, mainly from increases in thiamin (2.2% to 13.4%), cobalamin (1.8% to 9.8%), vitamin C (1.3% to 7.9%), vitamin E (1.8% to 8.7%), and zinc (0.2% to 3.3%). Female sex, higher education, and diabetes were associated with higher likelihood of supplement use. In 2018–2022, 4.8% of participants had potential drug-supplement interactions, most commonly vitamin E with aspirin (2.3%) and magnesium or potassium with antihypertensive medications. The likelihood of potential drug-supplement interactions was higher in women (OR = 2.03, 95%CI = 1.61–2.56), participants with primary education (OR = 1.45, 95% CI = 1.09–1.96), smokers (OR = 1.50, 95%CI = 1.07–2.12), and individuals with diabetes (OR = 2.80, 95%CI = 2.13–3.68), hypertension (OR = 2.20, 95%CI = 1.78–2.73), chronic kidney disease (OR = 2.35, 95%CI = 1.88–2.94), or multimorbidity (OR = 2.46, 95%CI = 1.85–3.26).</p><h3>Conclusion</h3><p>Over 16 years, supplement use increased among older adults, especially B-complex vitamins, vitamin C, vitamin E, and zinc, with a low but clinically relevant prevalence of drug-supplement interactions.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03344-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146224727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Intrinsic capacity (IC) is a core concept of the World Health Organization’s (WHO) Integrated Care for Older People (ICOPE), representing the composite of an individual’s physical and mental reserves. While deficits in IC are associated with reduced health-related quality of life (HRQoL), the functional mechanisms underlying this relationship, particularly the role of functional independence as measured by activities of daily living (ADL) remains underexplored. We investigated whether ADL performance mediates the association between IC and HRQoL among Chinese older adults.
Methods
In this cross-sectional analysis, 468 community-dwelling and institutionalized adults aged 60 years and older were recruited from the WHO ICOPE pilot in Lianyungang, China. Cumulative IC impairment was evaluated across five domains (cognition, locomotion, nutrition, sensory function, and psychology) using the ICOPE screening tool. ADL dependence was quantified by the Modified Barthel Index, and HRQoL was measured using the EQ-5D-3 L instrument. Multivariable logistic regression was employed to estimate the association between IC and HRQoL, adjusting for sociodemographic and clinical covariates. A nonparametric bootstrap mediation analysis (5000 resamples) quantified the indirect effect of IC on HRQoL via ADL.
Results
After adjusting for covariates, each one-point increase in Cumulative IC Impairment Score was associated with 46% higher odds of impaired HRQoL (adjusted OR = 1.46; 95% CI: 1.26–1.69; p < 0.001). ADL dependence mediated approximately 34.1% of this association (indirect effect = 0.028; 95% CI: 0.006–0.050; p = 0.013). Subgroup analyses revealed that the IC-HRQoL association was significantly stronger among urban residents compared to suburban residents (interaction p = 0.004) and among community-dwelling older adults compared to nursing home residents (interaction p = 0.043).
Conclusions
Intrinsic capacity impairment is associated with compromised HRQoL both directly and indirectly by exacerbating functional dependence. Preserving functional independence serves as a key pathway connecting intrinsic capacity to well-being. These findings highlight the imperative for integrated interventions that simultaneously bolster intrinsic capacity and support daily functional ability, tailored to diverse living environments to promote healthy aging.
{"title":"The mediating role of activities of daily living in the association between intrinsic capacity and health-related quality of life: evidence from the WHO ICOPE pilot in China","authors":"Zhen Wu, Haijun Zhao, Jiacheng Dong, Ping Yang, YinXia Li, Zhe Jin, Yiying Yang, Lulu Xiao, Linlin Hu, Yan Dong","doi":"10.1007/s40520-026-03347-x","DOIUrl":"10.1007/s40520-026-03347-x","url":null,"abstract":"<div><h3>Background</h3><p>Intrinsic capacity (IC) is a core concept of the World Health Organization’s (WHO) Integrated Care for Older People (ICOPE), representing the composite of an individual’s physical and mental reserves. While deficits in IC are associated with reduced health-related quality of life (HRQoL), the functional mechanisms underlying this relationship, particularly the role of functional independence as measured by activities of daily living (ADL) remains underexplored. We investigated whether ADL performance mediates the association between IC and HRQoL among Chinese older adults.</p><h3>Methods</h3><p>In this cross-sectional analysis, 468 community-dwelling and institutionalized adults aged 60 years and older were recruited from the WHO ICOPE pilot in Lianyungang, China. Cumulative IC impairment was evaluated across five domains (cognition, locomotion, nutrition, sensory function, and psychology) using the ICOPE screening tool. ADL dependence was quantified by the Modified Barthel Index, and HRQoL was measured using the EQ-5D-3 L instrument. Multivariable logistic regression was employed to estimate the association between IC and HRQoL, adjusting for sociodemographic and clinical covariates. A nonparametric bootstrap mediation analysis (5000 resamples) quantified the indirect effect of IC on HRQoL via ADL.</p><h3>Results</h3><p>After adjusting for covariates, each one-point increase in Cumulative IC Impairment Score was associated with 46% higher odds of impaired HRQoL (adjusted OR = 1.46; 95% CI: 1.26–1.69; <i>p</i> < 0.001). ADL dependence mediated approximately 34.1% of this association (indirect effect = 0.028; 95% CI: 0.006–0.050; <i>p</i> = 0.013). Subgroup analyses revealed that the IC-HRQoL association was significantly stronger among urban residents compared to suburban residents (interaction <i>p</i> = 0.004) and among community-dwelling older adults compared to nursing home residents (interaction <i>p</i> = 0.043).</p><h3>Conclusions</h3><p>Intrinsic capacity impairment is associated with compromised HRQoL both directly and indirectly by exacerbating functional dependence. Preserving functional independence serves as a key pathway connecting intrinsic capacity to well-being. These findings highlight the imperative for integrated interventions that simultaneously bolster intrinsic capacity and support daily functional ability, tailored to diverse living environments to promote healthy aging.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03347-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146211842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-17DOI: 10.1007/s40520-026-03340-4
Cecilie K. Netland, Dagfinn L. Markussen, Synne Jenum, Christian Ritz, Marit S. Bakken, Harleen M.S. Grewal
Background
Frailty assessment in the emergency department (ED) is essential but challenging. The Clinical Frailty Scale (CFS) is widely used, although inter-rater variability has been reported across assessors and assessment methods.
Aims
To assess agreement between ED-assigned and retrospectively assigned CFS scores, and to explore characteristics associated with changes in frailty classification.
Methods
We included 500 patients aged ≥ 65 years admitted with suspected pneumonia to Haukeland University Hospital (2019–2023). CFS was initially scored by nurses in the ED and reassessed retrospectively by a geriatric-trained physician using chart review. The retrospective assessment had access to broader and more objective information, including formal documentation from care services on daily function. CFS scores were categorized as fit (1–3), prefrail (4) and frail (5–9). Agreement was measured by Intraclass Correlation Coefficient (ICC).
Results
CFS scores changed numerically in 252 (50.4%) patients and frailty category in 144 (28.8%). Agreement was moderate to good (ICC 0.73; 95% CI 0.68–0.77; p < 0.001), with retrospective assessment yielding higher scores. Agreement was highest in frail (89.7%) and lowest in prefrail patients (44.8%). Recategorized patients were older, more comorbid, more often community-dwelling with greater care dependency, and had higher 1-year mortality.
Discussion
Real-time frailty assessments in the ED may underestimate frailty, particularly among patients who are community-dwelling, older, or have complex health conditions. Retrospective assessments, informed by objective documentation of functional needs, likely reflect baseline frailty more accurately.
Conclusions
Frailty is often underestimated in the ED. Improved access to collateral information may improve assessment accuracy.
背景:在急诊科(ED)虚弱评估是必要的,但具有挑战性。临床虚弱量表(CFS)被广泛使用,尽管在评估者和评估方法之间已经报道了不同评估者的差异。目的评估ed评分和回顾性评分之间的一致性,并探讨与衰弱分类变化相关的特征。方法纳入2019-2023年新西兰豪兰大学医院收治的500例年龄≥65岁的疑似肺炎患者。CFS最初由急诊科的护士评分,然后由一名接受过老年医学培训的医生使用图表回顾法对其进行回顾性评估。回顾性评估可以获得更广泛和更客观的信息,包括来自护理服务的关于日常功能的正式文件。CFS评分分为fit(1-3)、pre虚弱(4)和虚弱(5-9)。用类内相关系数(Intraclass Correlation Coefficient, ICC)衡量一致性。结果252例(50.4%)患者的scfs评分发生了数值变化,144例(28.8%)患者的虚弱类别发生了数值变化。一致性为中等至良好(ICC 0.73; 95% CI 0.68-0.77; p < 0.001),回顾性评估得分较高。体弱患者的一致性最高(89.7%),体弱前期患者的一致性最低(44.8%)。重新分类的患者年龄更大,合并症更多,更常居住在社区,护理依赖性更强,1年死亡率更高。急诊科的实时虚弱评估可能低估了虚弱,特别是在社区居民、老年人或有复杂健康状况的患者中。回顾性评估,根据功能需求的客观文件,可能更准确地反映基线虚弱。结论急诊科的脆弱性常被低估,改善对附带信息的获取可提高评估的准确性。
{"title":"Frailty classification challenges in the emergency department: agreement and variability in clinical frailty scale scoring","authors":"Cecilie K. Netland, Dagfinn L. Markussen, Synne Jenum, Christian Ritz, Marit S. Bakken, Harleen M.S. Grewal","doi":"10.1007/s40520-026-03340-4","DOIUrl":"10.1007/s40520-026-03340-4","url":null,"abstract":"<div><h3>Background</h3><p>Frailty assessment in the emergency department (ED) is essential but challenging. The Clinical Frailty Scale (CFS) is widely used, although inter-rater variability has been reported across assessors and assessment methods.</p><h3>Aims</h3><p>To assess agreement between ED-assigned and retrospectively assigned CFS scores, and to explore characteristics associated with changes in frailty classification.</p><h3>Methods</h3><p>We included 500 patients aged ≥ 65 years admitted with suspected pneumonia to Haukeland University Hospital (2019–2023). CFS was initially scored by nurses in the ED and reassessed retrospectively by a geriatric-trained physician using chart review. The retrospective assessment had access to broader and more objective information, including formal documentation from care services on daily function. CFS scores were categorized as fit (1–3), prefrail (4) and frail (5–9). Agreement was measured by Intraclass Correlation Coefficient (ICC).</p><h3>Results</h3><p>CFS scores changed numerically in 252 (50.4%) patients and frailty category in 144 (28.8%). Agreement was moderate to good (ICC 0.73; 95% CI 0.68–0.77; <i>p</i> < 0.001), with retrospective assessment yielding higher scores. Agreement was highest in frail (89.7%) and lowest in prefrail patients (44.8%). Recategorized patients were older, more comorbid, more often community-dwelling with greater care dependency, and had higher 1-year mortality.</p><h3>Discussion</h3><p>Real-time frailty assessments in the ED may underestimate frailty, particularly among patients who are community-dwelling, older, or have complex health conditions. Retrospective assessments, informed by objective documentation of functional needs, likely reflect baseline frailty more accurately.</p><h3>Conclusions</h3><p>Frailty is often underestimated in the ED. Improved access to collateral information may improve assessment accuracy.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03340-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146211868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1007/s40520-026-03343-1
Gianluca Canton, Andrea Marchetti, Andrea Sandrin, Belinda Trobec, Alex Buoite Stella, Paolo De Colle, Michela Zanetti, Luigi Murena, Chiara Ratti
Background
Periprosthetic hip fractures (PPHF) are a serious and increasingly frequent complication of hip arthroplasty, associated with significant morbidity and mortality in older adults.
Aims
To investigate the association between orthogeriatric assessment scores and six-month and one-year postoperative mortality in elderly patients undergoing surgery for PPHF.
Methods
A prospective registry of patients aged ≥ 65 years treated surgically for PPHF at Trieste University Hospital was analysed. Clinical, radiographic, and perioperative data were collected. Orthogeriatric scores, including the Mini Nutritional Assessment – Short Form (MNA-SF), Short Portable Mental Status Questionnaire (SPMSQ), Activities of Daily Living (ADL), Charlson Comorbidity Index (CCI), Parker Mobility Index, and Nottingham Hip Fracture Score (NHFS), were recorded on admission and at follow-up. Univariate analyses were performed to identify predictors of six-month and one-year mortality.
Results
Fifty-two patients (mean age 83.6 ± 8.1 years; 77% women) were included. The six-month and one-year mortality rates were 23.1% (12/52 patients) and 22.5% (9/40 patients), respectively. Higher mortality correlated significantly with poorer nutritional status (MNA-SF, p = 0.033; p = 0.011), lower cognitive performance (SPMSQ, p = 0.004, p = 0.002), reduced functional independence (ADL, p = 0.041, p = 0.026), and higher Nottingham Hip Fracture Scores (NHFS, p = 0.022, p = 0.047).
Conclusions
In conclusion, orthogeriatric scores, particularly MNA-SF, SPMSQ, ADL, and NHFS, are strong predictors of mortality after PPHF.
背景:髋关节假体周围骨折(PPHF)是髋关节置换术中一种严重且日益常见的并发症,在老年人中具有显著的发病率和死亡率。目的探讨老年PPHF手术患者正畸评估评分与术后6个月和1年死亡率之间的关系。方法对在里雅斯特大学医院接受手术治疗的年龄≥65岁的PPHF患者进行前瞻性登记分析。收集临床、影像学和围手术期资料。入院时和随访时记录正畸学评分,包括简易营养评估(MNA-SF)、简易便携式精神状态问卷(SPMSQ)、日常生活活动(ADL)、Charlson合并症指数(CCI)、Parker活动能力指数和诺丁汉髋部骨折评分(NHFS)。进行单变量分析以确定6个月和1年死亡率的预测因子。结果纳入52例患者,平均年龄83.6±8.1岁,女性占77%。6个月和1年死亡率分别为23.1%(12/52例)和22.5%(9/40例)。较高的死亡率与较差的营养状况(MNA-SF, p = 0.033; p = 0.011)、较低的认知能力(SPMSQ, p = 0.004, p = 0.002)、较低的功能独立性(ADL, p = 0.041, p = 0.026)和较高的诺丁汉髋部骨折评分(NHFS, p = 0.022, p = 0.047)显著相关。结论正老年病评分,尤其是MNA-SF、SPMSQ、ADL和NHFS是预测PPHF后死亡率的重要指标。
{"title":"Impact of orthogeriatric assessment on mortality in patients with periprosthetic hip fractures: a prospective study","authors":"Gianluca Canton, Andrea Marchetti, Andrea Sandrin, Belinda Trobec, Alex Buoite Stella, Paolo De Colle, Michela Zanetti, Luigi Murena, Chiara Ratti","doi":"10.1007/s40520-026-03343-1","DOIUrl":"10.1007/s40520-026-03343-1","url":null,"abstract":"<div><h3>Background</h3><p>Periprosthetic hip fractures (PPHF) are a serious and increasingly frequent complication of hip arthroplasty, associated with significant morbidity and mortality in older adults.</p><h3>Aims</h3><p>To investigate the association between orthogeriatric assessment scores and six-month and one-year postoperative mortality in elderly patients undergoing surgery for PPHF.</p><h3>Methods</h3><p>A prospective registry of patients aged ≥ 65 years treated surgically for PPHF at Trieste University Hospital was analysed. Clinical, radiographic, and perioperative data were collected. Orthogeriatric scores, including the Mini Nutritional Assessment – Short Form (MNA-SF), Short Portable Mental Status Questionnaire (SPMSQ), Activities of Daily Living (ADL), Charlson Comorbidity Index (CCI), Parker Mobility Index, and Nottingham Hip Fracture Score (NHFS), were recorded on admission and at follow-up. Univariate analyses were performed to identify predictors of six-month and one-year mortality.</p><h3>Results</h3><p>Fifty-two patients (mean age 83.6 ± 8.1 years; 77% women) were included. The six-month and one-year mortality rates were 23.1% (12/52 patients) and 22.5% (9/40 patients), respectively. Higher mortality correlated significantly with poorer nutritional status (<i>MNA-SF</i>, <i>p</i> = 0.033; <i>p</i> = 0.011), lower cognitive performance (<i>SPMSQ</i>, <i>p</i> = 0.004, <i>p</i> = 0.002), reduced functional independence (<i>ADL</i>, <i>p</i> = 0.041, <i>p</i> = 0.026), and higher <i>Nottingham Hip Fracture Scores</i> (<i>NHFS</i>, <i>p</i> = 0.022, <i>p</i> = 0.047).</p><h3>Conclusions</h3><p>In conclusion, orthogeriatric scores, particularly MNA-SF, SPMSQ, ADL, and NHFS, are strong predictors of mortality after PPHF.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03343-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146200134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-13DOI: 10.1007/s40520-026-03326-2
Lei Chen, Cong Hong, Yu Xie
We read the recent systematic review and meta-analysis on nutrition-based, gut microbiota–targeted interventions for sarcopenia in older adults with great interest. While the evidence suggests that probiotics and fiber-enriched diets may improve surrogate outcomes such as muscle strength and gait speed, we highlight two priorities to strengthen future mechanistic and clinical translation. First, microbiome measurements in existing trials are often limited to genus-level taxonomic shifts, which can be biologically misleading because a single genus may include members with divergent immunomodulatory properties. Even species-level profiling may be insufficient, as strains within the same species can differ markedly in genetic content and metabolic capacity. Moreover, taxonomic composition does not necessarily reflect functional output due to functional redundancy across microbial communities. We therefore recommend transitioning to whole-genome shotgun metagenomics to enable strain-level resolution and functional profiling, allowing investigators to quantify pathways and metabolites relevant to muscle preservation, including short-chain fatty acids and vitamin biosynthesis. Second, we argue that improvements in sarcopenia-defining parameters should be linked to patient-centered clinical benefit. Future randomized controlled trials should be adequately powered to assess hard endpoints, including falls, fractures, hospitalization rates, and functional independence, alongside muscle mass and performance measures, to establish whether microbiota modulation delivers meaningful reductions in healthcare burden.
{"title":"Bridging the gap between microbiome function and clinical benefit in sarcopenia","authors":"Lei Chen, Cong Hong, Yu Xie","doi":"10.1007/s40520-026-03326-2","DOIUrl":"10.1007/s40520-026-03326-2","url":null,"abstract":"<div><p>We read the recent systematic review and meta-analysis on nutrition-based, gut microbiota–targeted interventions for sarcopenia in older adults with great interest. While the evidence suggests that probiotics and fiber-enriched diets may improve surrogate outcomes such as muscle strength and gait speed, we highlight two priorities to strengthen future mechanistic and clinical translation. First, microbiome measurements in existing trials are often limited to genus-level taxonomic shifts, which can be biologically misleading because a single genus may include members with divergent immunomodulatory properties. Even species-level profiling may be insufficient, as strains within the same species can differ markedly in genetic content and metabolic capacity. Moreover, taxonomic composition does not necessarily reflect functional output due to functional redundancy across microbial communities. We therefore recommend transitioning to whole-genome shotgun metagenomics to enable strain-level resolution and functional profiling, allowing investigators to quantify pathways and metabolites relevant to muscle preservation, including short-chain fatty acids and vitamin biosynthesis. Second, we argue that improvements in sarcopenia-defining parameters should be linked to patient-centered clinical benefit. Future randomized controlled trials should be adequately powered to assess hard endpoints, including falls, fractures, hospitalization rates, and functional independence, alongside muscle mass and performance measures, to establish whether microbiota modulation delivers meaningful reductions in healthcare burden.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146177510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-11DOI: 10.1007/s40520-026-03335-1
Jack Dalla Via, Simone Radavelli-Bagatini, Marc Sim, Abadi K. Gebre, Catherine P. Bondonno, Kun Zhu, Shelby Mullin, John T. Schousboe, Richard J. Woodman, Markus P. Schlaich, Moira Sim, Pawel Szulc, Douglas P. Kiel, Wai H. Lim, Robin M. Daly, Jonathan M. Hodgson, Joshua R. Lewis
Background
Provision of vascular imaging results has been investigated to prompt changes towards healthy lifestyle behaviours, but effects on body composition and muscle health are unknown.
Aim
This secondary analysis of a 12-week parallel-group randomised controlled trial (RCT) aims to explore body composition and muscle health effects of providing healthy lifestyle education (Ed) with and without abdominal aortic calcification (AAC) results.
Methods
A total of 240 Australian community-dwelling older men and women (mean ± SD age 68 ± 5 years; 58% female; 57.1% with evidence of AAC) were randomised to AAC + Ed (n = 121) or Control + Ed (n = 119). Linear mixed models were used to compare between-group changes in body composition (dual-energy X-ray absorptiometry), grip strength, and subjective physical function.
Results
In total, 226 (94%) participants completed the trial. Provision of AAC results with lifestyle education provided no benefits to body composition, grip strength or physical function, compared to education alone. Exploratory analyses within the AAC + Ed group showed that those with evidence of AAC at baseline had greater declines in fat mass (net difference in change [95% CI] -0.6 [-1.0, -0.1] kg, p = 0.016) and visceral adipose tissue (-31 [-61, -1] g, p = 0.044) compared to those without evidence of AAC.
Conclusions
Providing AAC results with healthy lifestyle education did not improve body composition or muscle health in older adults, compared to education alone. Provision of AAC results to those with evidence of AAC at baseline did improve total and visceral fat mass compared to those without evidence of AAC, but these findings require further investigation.
Trial registration
Australian New Zealand Clinical Trial Registry (anzctr.org.au); registration number ACTRN12618001087246; registered 28/06/2018.
背景:已经研究了血管成像结果的提供,以促进健康生活方式行为的改变,但对身体成分和肌肉健康的影响尚不清楚。目的:对一项为期12周的平行组随机对照试验(RCT)进行二次分析,旨在探讨提供健康生活方式教育(Ed)对有或没有腹主动脉钙化(AAC)结果的身体成分和肌肉健康的影响。方法:共240名澳大利亚社区老年男性和女性(平均±SD年龄68±5岁;58%为女性;57.1%有AAC证据)被随机分为AAC + Ed (n = 121)或Control + Ed (n = 119)。采用线性混合模型比较组间身体成分(双能x线吸收测定法)、握力和主观身体功能的变化。结果:共有226名(94%)参与者完成了试验。与单独教育相比,提供生活方式教育的AAC结果对身体成分、握力或身体功能没有好处。在AAC + Ed组中进行的探索性分析显示,与没有AAC证据的患者相比,基线时有AAC证据的患者脂肪质量(变化的净差异[95% CI] -0.6 [-1.0, -0.1] kg, p = 0.016)和内脏脂肪组织(-31 [-61,-1]g, p = 0.044)的下降幅度更大。结论:与单独教育相比,提供AAC结果与健康生活方式教育并不能改善老年人的身体成分或肌肉健康。与无AAC证据的患者相比,向基线时有AAC证据的患者提供AAC结果确实改善了总脂肪量和内脏脂肪量,但这些发现需要进一步研究。试验注册:澳大利亚新西兰临床试验注册中心(anzctr.org.au);注册号ACTRN12618001087246;28/06/2018注册。
{"title":"Body composition and muscle health changes after providing vascular imaging results in older adults: secondary analysis of a randomised controlled trial","authors":"Jack Dalla Via, Simone Radavelli-Bagatini, Marc Sim, Abadi K. Gebre, Catherine P. Bondonno, Kun Zhu, Shelby Mullin, John T. Schousboe, Richard J. Woodman, Markus P. Schlaich, Moira Sim, Pawel Szulc, Douglas P. Kiel, Wai H. Lim, Robin M. Daly, Jonathan M. Hodgson, Joshua R. Lewis","doi":"10.1007/s40520-026-03335-1","DOIUrl":"10.1007/s40520-026-03335-1","url":null,"abstract":"<div><h3>Background</h3><p>Provision of vascular imaging results has been investigated to prompt changes towards healthy lifestyle behaviours, but effects on body composition and muscle health are unknown.</p><h3>Aim</h3><p>This secondary analysis of a 12-week parallel-group randomised controlled trial (RCT) aims to explore body composition and muscle health effects of providing healthy lifestyle education (Ed) with and without abdominal aortic calcification (AAC) results.</p><h3>Methods</h3><p>A total of 240 Australian community-dwelling older men and women (mean ± SD age 68 ± 5 years; 58% female; 57.1% with evidence of AAC) were randomised to AAC + Ed (<i>n</i> = 121) or Control + Ed (<i>n</i> = 119). Linear mixed models were used to compare between-group changes in body composition (dual-energy X-ray absorptiometry), grip strength, and subjective physical function.</p><h3>Results</h3><p>In total, 226 (94%) participants completed the trial. Provision of AAC results with lifestyle education provided no benefits to body composition, grip strength or physical function, compared to education alone. Exploratory analyses within the AAC + Ed group showed that those with evidence of AAC at baseline had greater declines in fat mass (net difference in change [95% CI] -0.6 [-1.0, -0.1] kg, <i>p</i> = 0.016) and visceral adipose tissue (-31 [-61, -1] g, <i>p</i> = 0.044) compared to those without evidence of AAC.</p><h3>Conclusions</h3><p>Providing AAC results with healthy lifestyle education did not improve body composition or muscle health in older adults, compared to education alone. Provision of AAC results to those with evidence of AAC at baseline did improve total and visceral fat mass compared to those without evidence of AAC, but these findings require further investigation.</p><h3>Trial registration</h3><p>Australian New Zealand Clinical Trial Registry (anzctr.org.au); registration number ACTRN12618001087246; registered 28/06/2018.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-026-03335-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146155812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-07DOI: 10.1007/s40520-026-03336-0
Alyssa C. Zhu, Casandra R. Mysior, Lisa R. LaRowe, Peter M. Abadir, Laura Haines, Jack Chan, Rebecca A. Aslakson
Background
Low back pain (LBP) is a global health problem that contributes to disability, psychological distress, and reduced quality of life in older adults. Current treatment guidelines for LBP support the use of conservative therapies such as physical therapy alongside medication management. However, interventional pain management strategies for LBP such as lumbar epidural steroid injection (LESI) are rarely mentioned.
Aims
We conducted this systematic review to characterize and evaluate the use and effectiveness of LESI amongst older adults with LBP.
Methods
We conducted a systematic English-language literature search of Ovid MEDLINE, Ovid EMBASE, and Cochrane Library. We used an iterative approach to identify both keywords and controlled vocabulary related to treatment outcomes of epidural interventions for LBP among older adults. The results were reviewed by three members of the team.
Results
Our search of 3 databases produced a total of 2657 studies and 12 met final inclusion criteria. In all studies, the use of LESI was associated with improvement in pain and/or quality of life.
Discussion
As compared to medication management, LESI was associated with statistically significant improvements in pain and functional status. The addition of physical therapy was not superior to LESI alone.
Conclusions
This systematic review is the first that focuses on the effectiveness of LESI in managing LBP in older adults. This review suggests that LESI may reduce pain and improve functional status in older adults, particularly as compared to medication management.
Prospero registration
The study was prospectively registered on Prospero (ID # 422087).
{"title":"Effectiveness of epidural steroid injections for low back pain in older adults: a systematic review","authors":"Alyssa C. Zhu, Casandra R. Mysior, Lisa R. LaRowe, Peter M. Abadir, Laura Haines, Jack Chan, Rebecca A. Aslakson","doi":"10.1007/s40520-026-03336-0","DOIUrl":"10.1007/s40520-026-03336-0","url":null,"abstract":"<div><h3>Background</h3><p>Low back pain (LBP) is a global health problem that contributes to disability, psychological distress, and reduced quality of life in older adults. Current treatment guidelines for LBP support the use of conservative therapies such as physical therapy alongside medication management. However, interventional pain management strategies for LBP such as lumbar epidural steroid injection (LESI) are rarely mentioned.</p><h3>Aims</h3><p>We conducted this systematic review to characterize and evaluate the use and effectiveness of LESI amongst older adults with LBP.</p><h3>Methods</h3><p>We conducted a systematic English-language literature search of Ovid MEDLINE, Ovid EMBASE, and Cochrane Library. We used an iterative approach to identify both keywords and controlled vocabulary related to treatment outcomes of epidural interventions for LBP among older adults. The results were reviewed by three members of the team.</p><h3>Results</h3><p>Our search of 3 databases produced a total of 2657 studies and 12 met final inclusion criteria. In all studies, the use of LESI was associated with improvement in pain and/or quality of life.</p><h3>Discussion</h3><p>As compared to medication management, LESI was associated with statistically significant improvements in pain and functional status. The addition of physical therapy was not superior to LESI alone.</p><h3>Conclusions</h3><p>This systematic review is the first that focuses on the effectiveness of LESI in managing LBP in older adults. This review suggests that LESI may reduce pain and improve functional status in older adults, particularly as compared to medication management.</p><h3>Prospero registration</h3><p>The study was prospectively registered on Prospero (ID # 422087).</p><h3>Clinical trial number</h3><p>Not Applicable.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"38 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146130846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}